BUD Revenue Growth (YoY) Analysis
Updated 203h ago·SEC filings & market data
Key Takeaway
Revenue growth (year-over-year) measures the percentage change in sales compared to the same quarter last year.
Sector Performance
59th percentileBUD
11.0%
Sector Median
9.2%
Sector Avg
14.7%
Prior Period
12.0%(Jul 2026)
Deep Analysis
Revenue growth (year-over-year) measures the percentage change in sales compared to the same quarter last year.
At 12.0%, BUD’s sales are expanding faster than the sector median of 5.3%, placing it in the 92nd percentile among Consumer Defensive peers. The metric is increasing; the latest quarterly figure jumped from 1.9% to 12.0%, yielding a quarter-over-quarter change of +531.6%, while the year-over-year change is not available. A high growth rate combined with a sharp upward trend signals that recent business momentum is accelerating, which can reduce risk for investors. This strength supports the NEUTRAL overall verdict, as the metric
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about BUD?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
Who are BUD's closest peers by Revenue Growth (YoY)?
The closest peers by Revenue Growth (YoY) include: FCX (-7.3%), INSP (-7.6%), FOX (-8.6%), NVR (-10.5%), HES (-11.2%).
Learn More About Revenue Growth (YoY)
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master BUD's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full BUD research report →BUD
11.0%
Sector Median
9.2%
Sector Avg
14.7%
How BUD's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.